Evidence map›Paper›PMID 35766873›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

Serum 25-Hydroxyvitamin D is Associated With Bone Microarchitecture and Strength in a Multiracial Cohort of Young Adults.

Margaret Garrahan, Sarah Gehman, Sara E Rudolph, Adam S Tenforde, Kathryn E Ackerman, Kristin L Popp, Mary L Bouxsein, Shivani Sahni

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Margaret GarrahanEndocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0002-4933-8016
Sarah GehmanEndocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
Sara E RudolphEndocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
Adam S TenfordeHarvard Medical School, Boston, MA 02215, USA.
Kathryn E AckermanEndocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
Kristin L PoppEndocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
Mary L BouxseinEndocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0002-7027-7414
Shivani SahniHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02131, USA.ORCID 0000-0002-9827-0986

Funding

X-Treme CT Equipment GrantS10RR023405 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI FINKELSTEIN, JOEL S · 2007 to 2007
$380k
NCRR NIH HHS S10 RR023405
6 · The paper itself

Abstract

purposeTo determine whether 25-hydroxyvitamin D (25-OH D) levels are associated with bone outcomes in a multiracial cohort of young adults.

methodsThis cross-sectional study included 165 participants (83 men, 82 women, 18-30 years of age) who self-identified as Asian, Black, or White. We measured bone microarchitecture and strength of the distal radius and tibia using high-resolution peripheral quantitative computed tomography. We used linear regression to estimate the association between 25-OH D (ng/mL) and bone measurements, adjusting for race, sex, age, weight, height, calcium intake, physical activity, and season.

resultsA total of 43.6% of participants were 25-OH D deficient (<20 ng/mL) with greater prevalence in Asian (38.9%) and Black (43.1%) compared with White (18.0%) participants (P < 0.001). At the distal radius, 25-OH D was positively associated with cortical area, trabecular density, cortical thickness, cortical porosity, and failure load (P < 0.05 for all). At the distal tibia, higher 25-OH D was associated with higher cortical area, trabecular density, trabecular number, failure load, and lower trabecular separation and cortical density (P < 0.05 for all). After multivariable adjustment, those with 25-OH D deficiency had generally worse bone microarchitecture than those with 25-OH D sufficiency. Black individuals had largely more favorable bone outcomes than Asian and White individuals, despite higher prevalence of 25-OH D deficiency.

conclusionsWe found a high prevalence of 25-OH D deficiency in a multiracial cohort of young adults. Lower 25-OH D was associated with worse bone outcomes at the distal radius and tibia at the time of peak bone mass, warranting further attention to vitamin D status in young adults.

Indexed as

Bone and BonesBone DensityAbsorptiometry, PhotonCalcifediolCross-Sectional StudiesFemaleHumansMaleRadiusTibiaVitamin DYoung Adult25-hydroxyvitamin DCalcifediolVitamin Dbone microarchitecturemultiracial cohortvitamin D

Identifiers

PMID35766873
PMCPMC9387703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.